Articles tagged as

Drug Manufacturers - Major

  1. Healthcare M&A and Prescription Drug Prices

  2. Valeant Pharmaceuticals acquires Sprout Pharmaceuticals

  3. ETF Analysis: PowerShares Dynamic Pharmaceuticals

  4. Is the Ebola Epidemic Officially Over?

  5. Sarepta Therapeutics Made Investors Millionaires in 2 Years

  6. Celgene Vs. Gilead: Vetting for the Best Biopharma

  7. Make Room for Exelixis in Your Portfolio

  8. Drugmaker Extraordinaire: How Eli Lilly Grows

  9. ETF Analysis: Market Vectors Pharmaceutical

  10. Are Bears About to Burst the Biotech Bubble?

  11. Pfizer CEO: The Story Behind Ian Read

  12. 10 Developments By Gilead Sciences That Could Boost Profits

  13. Are These 2015's 10 Best Generic Pharma Stocks?

  14. How to Profit from the Generic Drug Trend

  15. From Startup To Blue Chip: The Success Story Of Gilead Sciences Inc.

  16. Top 10 Pfizer Venture Investments

  17. Is It Too Late To Invest In Gilead Sciences?

  18. How Does Biogen Make its Money?

  19. Small-Cap Biotech Stocks to Watch

  20. Are These the Top 3 Value Stocks of 2015?

  21. 3 Top Pharma Stocks that Pay Regular Dividends

  22. How to Analyze Pharma Stock Fundamentals

  23. How Bristol-Myers Squibb Makes the World Healthier

  24. How is a Spinoff Worth $100 Billion? See AbbVie

  25. Why These Could Be 2015's 10 Best Biotech Stocks

  26. Why These Could Be 2015's 10-Best Pharma Stocks

  27. Why These ETFs are the Best Way to Trade Pfizer

  28. Could Amgen's Next Drug Be Worth $100 Billion?

  29. Has The Time Come To Sell Vertex Pharmaceuticals?

  30. Why Celgene Won't Pay A Dividend Anytime Soon

  31. Could This Drug Make Isis Pharmaceuticals Soar?

  32. What Biotech Stock To Buy When The Market Tumbles?

  33. Did Orexigen Make A Big Mistake?

  34. Are These Biogen Idec's Next Blockbusters?

  35. Why Does Wall Street Hate MannKind?

  36. Is Exelixis Under-the-Radar Growth?

  37. Is Arena Pharmaceuticals In Trouble?

  38. What’s The Drug That Will Finally Fight Obesity?

  39. Should You Invest In Oraganovo Holdings?

  40. What Is Amgen’s New Target?

  41. Will MannKind Finally Reach A Solid Ground?

  42. Should We Be Concerned For Sarepta’s Share Prices?

  43. What Are The Real Economic Costs Of Obesity?

  44. Gilead Sciences: The New Market-Share Leader

  45. Sun Pharma And Ranbaxy: An Ideal Pharma Marriage?

  46. Dilip Shanghvi's Net Worth: How Did He Get So Rich?

  47. How Amgen Makes Billions On Just A Few Drugs

  48. How Merck Found Its Way Into Millions Of Medicine Cabinets

  49. How Gilead Sciences Became A Big Name In Biotech

  50. Want To Make Money In Marijuana? Read This First

  51. What Are The Best Bets In Biotech?

  52. How Some Brands Come Back from Near Death

  53. It's No Accident That Drugs Are Expensive

  54. Will Immunotherapy Disrupt The Oncology Market?

  55. 8 Stages Of New Drug Development

  56. Big Pharma Faces 'Pay For Delay' Lawsuits

Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!